Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | STAMBPL1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | MICALL1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
mRNA | LAT2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
mRNA | FUZ | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | ZNF618 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | H2AFY | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | STK4 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
mRNA | CTD-3148I10.9 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
mRNA | ITGB1BP1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | MOGS | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |